Company News
Jubilant Pharmova Subsidiary Gets Tentative USFDA Pantoprazole Approval
Jubilant Generics receives tentative USFDA approval for Pantoprazole Sodium Delayed Release Oral Suspension, 40mg.
Final approval is contingent on the expiry of the reference drug's patent in December